The Pharma Data

MAY 1, 2023

An additional secondary analysis further demonstrated lebrikizumab’s stable and long-lasting results at one year of treatment in patients with moderate-to-severe atopic dermatitis (AD), commonly called eczema. ” About Lilly Lilly unites caring with discovery to create medicines that make life better for people around the world.

Dermatology 40

Dermatology Medicine Clinical Trials Clinical Trials 40

pharmaphorum

FEBRUARY 18, 2021

From drug discovery and development through to manufacturing and patient treatment, technology will create new opportunities at every stage of the healthcare process.”. billion to bring a drug to market, it has never felt so critical that we embrace this powerful pairing. At a time when it still takes 12.5 years and $2.5

Medicine 90

Medicine Pharma Companies Clinical Trials Clinical Trials 90

pharmaphorum

DECEMBER 1, 2022

Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials. A 2018 NIH survey found that patients felt clinical trial participation to be inconvenient and burdensome, and nearly half (49.0%) said it disrupted their daily routine.

Clinical Trials 108

Clinical Trials Clinical Trials Trials Clinical Research 108

The Pharma Data

FEBRUARY 21, 2022

At its annual Pharma Media Day 2022, Bayer presented the latest developments in the ongoing transformation of its pharmaceuticals business, which is aimed at delivering long-term, sustainable business growth by bringing forward new options for patients. “We

Radiology 52

Radiology Cardiology Development Production 52

pharmaphorum

MAY 19, 2022

“If the European Health Data Space (EHDS) and the rules surrounding access to the data are not carefully thought through, with the involvement of all stakeholders, there could be unintended consequences that limit the utility of the data for developing innovative medicines,” said the organisation. Huge potential.

Genome 52

Genome Genomics Medicine Research 52

The Pharma Data

JUNE 7, 2023

Moderna and Merck Announce mRNA-4157 (V940) in Combination With KEYTRUDA® (pembrolizumab) Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Distant Metastasis-Free Survival (DMFS) in Patients with High-Risk Stage III/IV Melanoma Following Complete Resection Versus KEYTRUDA Moderna, Inc.

Clinical Trials 40

Clinical Trials Clinical Trials HR Medicine 40

Drug Discovery World

JUNE 1, 2023

“Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combining the power of Seagen’s antibody-drug conjugate (ADC) technology with the scale and strength of Pfizer’s capabilities and expertise.

Antibody 98

Antibody Marketing Drugs Licensing 98

Drug Discovery World

MARCH 6, 2024

The development of effective new disease-modifying treatments in neurodegenerative and neuropsychiatric disorders has been hindered by their inherent genetic complexity, environmental influences, and clinical variability. This is comparatively easier to accomplish in these diseases because they are relatively monogenic.

Genome 64

Genome Genomics Clinical Trials Clinical Trials 64

The Pharma Data

JANUARY 6, 2021

The research collaboration is aimed at identifying novel lead compounds and repurposing existing drugs for rheumatoid arthritis and nonalcoholic steatohepatitis, leveraging Standigm’s AI-powered drug discovery platforms : Standigm BEST , Standigm Insight , and Standigm ASK. Learn more at [link]. About SK Chemicals. Learn more at [link].

FDA Approval 52

FDA Approval Life Science Drugs In-Vivo 52

The Pharma Data

JUNE 7, 2022

Eli Lilly and Company (NYSE: LLY) today announced topline results from one-year analyses of the efficacy and safety of lebrikizumab, the company’s investigational IL-13 inhibitor for the treatment of patients with moderate-to-severe atopic dermatitis (AD). vice president of global immunology development and medical affairs at Lilly.

Trials 40

Trials Clinical Trials Clinical Trials Medicine 40

The Pharma Data

OCTOBER 19, 2020

Caris’ collaborative network focused on expanding the application of precision medicine in oncology supports Winship’s enterprising approach to research leading to transformative discoveries in cancer care and treatment. IRVING, Texas and ATLANTA , Oct. MBA, FACP, Chairman of the Caris Precision Oncology Alliance.

Life Science 52

Life Science Clinical Trials Clinical Trials RNA 52

The Pharma Data

MARCH 16, 2021

By combining our expertise, we hope to make significant steps forward to finding solutions for patients for which there currently is no treatment.”. Making new and better medicines for humans and animals is at the heart of what we do. Hugh Marston, Ph.D., Head of Department CNS Diseases Research at Boehringer Ingelheim. “By

Development 52

Development Contract Manufacturing Licensing Licensing 52

The Pharma Data

OCTOBER 14, 2020

Priothera will use the funds to progress the clinical development of mocravimod, a modulator of sphingosine 1 phosphate (S1P) receptors, to enhance the curative potential of allogeneic hematopoietic stem cell transplantation (HSCT) for treating AML. VBL is currently advancing its lead anti-MOSPD2 candidate through IND-enabling studies.

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing Trials 52

Drug Discovery World

OCTOBER 17, 2023

In the medium term, we will also see the emergence of full-on spatial biologists who combine expertise in both fields, but till then working together is more than just a stopgap solution. RA: Can spatial biology studies help drive advances in precision medicine? A single patient sample can yield terabytes of data.

Gene Expression 52

Gene Expression Drugs Protein Gene 52

XTalks

MAY 20, 2021

Some of the main themes in the clinical trials space during the past year have been more widespread adoption of decentralized trials (DCT) — leveraging modern, digital technologies — increased patient inclusion and diversity and an increased positive perception of the value and importance of clinical trials among the general public.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Vaccination 105

Drug Discovery World

OCTOBER 10, 2022

As a result, many apparently attractive new drug candidates in neuroscience subsequently fail to meet their primary endpoints in clinical trials. Psychiatric and neurological drug development is entering a new realm where stratified approaches are finally being applied successfully. The solution provided by digital biomarkers.

Development 52

Development Drugs Clinical Trials Clinical Trials 52

The Pharma Data

APRIL 7, 2023

Merck and Eisai are informing study investigators of the decision and advising them to reach out to patients in the study regarding treatment. With the LEAP-003 and LEAP-017 trials, we set out to help improve outcomes for patients with two difficult-to-treat advanced cancers, melanoma and colorectal cancer,” said Corina Dutcus, M.D.,

Trials 40

Trials Clinical Trials Clinical Trials Development 40

The Pharma Data

APRIL 4, 2023

First approved therapeutic regimen that combines an anti-PD-1 and an antibody-drug conjugate in the US in these patients Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. in these patients. confirmatory trial for the accelerated approval.

FDA Approval 40

FDA Approval Containment Hormones Dermatology 40

The Pharma Data

DECEMBER 8, 2020

Phase 3 TETON study planned in 2021 for Tyvaso® in patients with idiopathic pulmonary fibrosis. United Therapeutics intends to initiate a phase 3 study, called TETON , to evaluate the use of Tyvaso ® (treprostinil) Inhalation Solution in patients with IPF. About TYVASO ® (treprostinil) Inhalation Solution. INDICATION.

Drugs 40

Drugs FDA Approval Marketing Containment 40

XTalks

DECEMBER 24, 2020

The most positive thing to be gleaned from the pandemic is how it allowed for the power and pursuit of science to shine. Researchers isolated the virus from nasopharyngeal and oropharyngeal samples from the infected patient and characterized its sequence and replication properties. Drugs, Testing and Vaccines.

Life Science 111

Life Science Vaccination Vaccine Gene 111

pharmaphorum

NOVEMBER 3, 2022

Food and Drug Administration’s (FDA) draft guidance, “ Digital Health Technologies for Remote Data Acquisition in Clinical Investigations ”. The Digital Medicine Society’s Library of Digital Endpoints surpassed 350 unique digital endpoints used for evaluating new medical products. Moving towards implementation.

Clinical Trials 81

Clinical Trials Clinical Trials Trials Medicine 81

pharmaphorum

OCTOBER 7, 2021

This makes diagnosis a very difficult and often exceptionally slow process, leaving patients and their families feeling isolated and vulnerable. However, developments in genomic medicine are making huge strides to improve this situation, and these will also be discussed during the webinar. Learn more at www.iqvia.com.

Genome 97

Genome Genomics Medicine Life Science 97

pharmaphorum

SEPTEMBER 12, 2022

Dr Prasanth Reddy, head of oncology at LabCorp, tells us how the company works with cancer care teams, biopharma partners, and patients as an integral part of the patient journey from testing to treatment. Personalised medicine looks at developing or utilising treatments that target those differences.

Genome 103

Genome Genomics Clinical Trials Clinical Trials 103

The Pharma Data

SEPTEMBER 8, 2020

Together, these nine companies have collectively developed more than 70 novel vaccines that have helped to eradicate some of the world’s most complex and deadly public health threats, underscoring their experience in clinical development and regulatory rigor, as well as their longstanding commitments to patient safety and public health.

Vaccination 52

Vaccination Vaccine Containment Clinical Trials 52

The Pharma Data

DECEMBER 10, 2020

ImmunityBio has engineered the vector to overcome this problem and has shown that its second-generation adenovirus vector can safely and effectively deliver its cargo even in patients with pre-existing adenovirus immunity. NantKwest is the leading producer of clinical dose forms of off-the-shelf natural killer (NK) cell therapies.

Vaccination 52

Vaccination Vaccine Immune Response Protein 52

The Pharma Data

SEPTEMBER 8, 2020

Together, these nine companies have collectively developed more than 70 novel vaccines that have helped to eradicate some of the world’s most complex and deadly public health threats, underscoring their experience in clinical development and regulatory rigor, as well as their longstanding commitments to patient safety and public health.

Vaccination 52

Vaccination Vaccine Containment Clinical Trials 52

pharmaphorum

JANUARY 16, 2023

Even where there has been innovation, for example in cholesterol lowering with PCSK-9s and the siRNA treatment Leqvio, the vast majority of patients are on generic versions of medicines launched in the 1990s, and innovative medicines have not transformed the treatment paradigm. Innovation will power the market.

Gene Therapy 89

Gene Therapy In-Vitro Gene Medicine 89

pharmaphorum

OCTOBER 10, 2022

Detecting patients with cancer as early as possible gives clinicians the best chance to formulate a successful treatment response. Any delay in diagnosis or treatment can severely impact the options available to patients and healthcare professionals. Time is a precious resource in oncology.

Development 93

Development Research Marketing Life Science 93

pharmaphorum

DECEMBER 14, 2022

As many strive to bring about transformation in healthcare, Angelini Ventures takes a new approach to investments in digital health and life sciences companies that drive healthcare innovation and improve patient experiences. Serenis provides a unique platform that matches patients in need with certified therapists.

Life Science 105

Life Science Development Business Development Genetics 105

XTalks

SEPTEMBER 14, 2020

It, too, is now in Phase III human trials, with an earlier trial showing that after seven days of receiving a second dose of their vaccine, the BNT162b2 candidate vaccine induced neutralizing antibodies in adults up to the age of 55 years that were almost four times higher than levels seen in blood taken from previously infected patients.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92

Pharma Marketing Network

APRIL 30, 2021

Protocols, which have remained substantively unchanged for over 30 years, often impose an immense burden on patient participants, largely due to the frequency of site visits. Across the board, from rheumatology to neurology, outcomes that matter most to patients, have traditionally not been captured in clinical trials.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Regulation 52